338 related articles for article (PubMed ID: 10716484)
1. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.
Zhu B; Sun Y; Sievers RE; Browne AE; Pulukurthy S; Sudhir K; Lee RJ; Chou TM; Chatterjee K; Parmley WW
J Am Coll Cardiol; 2000 Mar; 35(3):787-95. PubMed ID: 10716484
[TBL] [Abstract][Full Text] [Related]
2. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
Ozer MK; Sahna E; Birincioglu M; Acet A
Pharmacol Res; 2002 Apr; 45(4):257-63. PubMed ID: 12030787
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
Zhu BQ; Sievers RE; Browne AE; Lee RJ; Chatterjee K; Grossman W; Karliner JS; Parmley WW
J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):31-7. PubMed ID: 12692751
[TBL] [Abstract][Full Text] [Related]
4. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
Parlakpinar H; Ozer MK; Acet A
Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
[TBL] [Abstract][Full Text] [Related]
5. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
Lynch JJ; Stump GL; Wallace AA; Painter CA; Thomas JM; Kusma SE; Gould RJ; Grossman W
J Am Coll Cardiol; 1999 Sep; 34(3):876-84. PubMed ID: 10483973
[TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin system does not contribute to the endothelial dysfunction and increased infarct size in rats exposed to second hand smoke.
Zhu BQ; Sievers RE; Browne AE; Hillman RT; Chair K; Lee RJ; Chatterjee K; Glantz SA; Parmley WW
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):54-60. PubMed ID: 11984749
[TBL] [Abstract][Full Text] [Related]
7. Effects of different durations of pretreatment with losartan on myocardial infarct size, endothelial function, and vascular endothelial growth factor.
Zhu B; Sun Y; Sievers RE; Browne AE; Lee RJ; Chatterjee K; Parmley WW
J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):129-33. PubMed ID: 11881112
[TBL] [Abstract][Full Text] [Related]
8. Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats.
Lee YM; Peng YY; Ding YA; Yen MH
Am J Hypertens; 1997 Aug; 10(8):852-8. PubMed ID: 9270079
[TBL] [Abstract][Full Text] [Related]
9. Survival after myocardial infarction in rats: captopril versus losartan.
Milavetz JJ; Raya TE; Johnson CS; Morkin E; Goldman S
J Am Coll Cardiol; 1996 Mar; 27(3):714-9. PubMed ID: 8606287
[TBL] [Abstract][Full Text] [Related]
10. Protection against ventricular arrhythmias and cardiac death using adenosine and lidocaine during regional ischemia in the in vivo rat.
Canyon SJ; Dobson GP
Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1286-95. PubMed ID: 15317678
[TBL] [Abstract][Full Text] [Related]
11. Influence of ramiprilat and losartan on ischemia reperfusion injury in rat hearts.
Safari F; Hajizadeh S; Shekarforoush S; Bayat G; Foadoddini M; Khoshbaten A
J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):29-35. PubMed ID: 22076778
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in rats.
Ozhan O; Parlakpinar H; Acet A
Fundam Clin Pharmacol; 2021 Aug; 35(4):669-680. PubMed ID: 32810901
[TBL] [Abstract][Full Text] [Related]
13. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
[TBL] [Abstract][Full Text] [Related]
14. Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study.
Di Pasquale P; Bucca V; Scalzo S; Cannizzaro S; Giubilato A; Paterna S
Heart; 1999 Jun; 81(6):606-11. PubMed ID: 10336919
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
16. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
[TBL] [Abstract][Full Text] [Related]
17. [Reduction of incidence of ischemia-reperfusion induced ventricular fibrillation by captopril].
Zhang M; Pan JY; Zhu XN; Zhan CY
Sheng Li Xue Bao; 1995 Dec; 47(6):559-64. PubMed ID: 8762446
[TBL] [Abstract][Full Text] [Related]
18. Effects of KR-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarction and arrhythmias induced by ischemia and reperfusion.
Lee BH; Yi KY; Lee S; Lee S; Yoo SE
Eur J Pharmacol; 2005 Oct; 523(1-3):101-8. PubMed ID: 16226744
[TBL] [Abstract][Full Text] [Related]
19. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.
Møller JE; Dahlström U; Gøtzsche O; Lahiri A; Skagen K; Andersen GS; Egstrup K;
Am Heart J; 2004 Mar; 147(3):494-501. PubMed ID: 14999200
[TBL] [Abstract][Full Text] [Related]
20. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.
Dickstein K; Kjekshus J;
Lancet; 2002 Sep; 360(9335):752-60. PubMed ID: 12241832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
